Furthermore, PALB2 is the most frequently altered gene (1.2%) in non BRCA1/2 mutated male breast cancer patients, accordingly the risk of MBC increases from 9.63 to 17.30-fold in presence of PALB2 pathogenetic variants (28). Here, PALB2 is linked to breast cancer.